Additional Bibliography
51
Cooper S, Erickson AL, Adams EJ, et al. Analysis of a successful immune
response against hepatitis C virus. Immunity 1999;10(4):439-49.
52
Thimme R, Oldach D, Chang KM, et al. Determinants of viral clearance
and persistence during acute hepatitis C virus infection. J Exp Med
2001;194(10):1395-406.
53
Della Bella S, Riva A, Tanzi E, et al. Hepatitis C virus-specific reactivity of
CD4+-lymphocytes in children born from HCV-infected women. J Hepatol
2005;43(3):394-402.
54
England K, Pembrey L, Tovo PA, et al. Excluding hepatitis C virus (HCV)
infection by serology in young infants of HCV-infected mothers. Acta
Paediatr 2005;94(4):444-50.
55
Meunier JC, Bukh J, Diaz G, et al. Neutralizing antibodies to hepatitis C
virus in perinatally infected children followed up prospectively. J Infect Dis
2011;204(11):1741-5.
56
Delamare C, Carbonne B, Heim N, et al. Detection of hepatitis C virus
RNA (HCV RNA) in amniotic fluid: a prospective study. J Hepatol
1999;31(3):416-20.
57
Hurtado CW, Golden-Mason L, Brocato M, et al. Innate immune function
in placenta and cord blood of hepatitis C--seropositive mother-infant dyads.
PLoS One 2010;5(8):e12232.
58
Paternoster DM, Belligoli A, Ngaradoumbe NK, et al. Endogenous
interferon-alpha level is increased in hepatitis C virus (HCV)-positive
pregnant women. J Clin Gastroenterol 2008;42(2):204-7.
59
Arshad M, El-Kamary SS, Jhaveri R Hepatitis C virus infection during
pregnancy and the newborn period--are they opportunities for treatment? J
Viral Hepat 2011;18(4):229-36.
60
Chary A, Winters MA, Eisen R, et al. Quantitation of hepatitis C virus
RNA in peripheral blood mononuclear cells in HCV-monoinfection and
HIV/HCV-coinfection. J Med Virol 2012;84(3):431-7.
61
Laskus T, Operskalski EA, Radkowski M, et al. Negative-strand hepatitis C
virus (HCV) RNA in peripheral blood mononuclear cells from anti-HCVpositive/HIV-infected women. J Infect Dis 2007;195(1):124-33.
62
Azzari C, Resti M, Moriondo M, et al. Vertical transmission of HCV is
related to maternal peripheral blood mononuclear cell infection. Blood
2000;96(6):2045-8.
63
Jacobson IM, McHutchison JG, Dusheiko G, et al. Telaprevir for
previously untreated chronic hepatitis C virus infection. N Engl J Med
2011;364(25):2405-16.
64
Poordad F, McCone J, Jr., Bacon BR, et al. Boceprevir for untreated
chronic HCV genotype 1 infection. N Engl J Med 2011;364(13):1195-206.
65
Delgado-Borrego A, Smith L, Jonas MM, et al. Expected and actual case
ascertainment and treatment rates for children infected with hepatitis C in
Florida and the United States: epidemiologic evidence from statewide and
nationwide surveys. J Pediatr 2012;161(5):915-21.
66
Smith BD, Morgan RL, Beckett GA, et al. Hepatitis C virus testing of
persons born during 1945-1965: recommendations from the Centers for
Disease Control and Prevention. Ann Intern Med 2012;157(11):817-22.
67
Han GR, Cao MK, Zhao W, et al. A prospective and open-label study for
the efficacy and safety of telbivudine in pregnancy for the prevention of
perinatal transmission of hepatitis B virus infection. J Hepatol
2011;55(6):1215-21.
68
Pan CQ, Mi LJ, Bunchorntavakul C, et al. Tenofovir disoproxil fumarate
for prevention of vertical transmission of hepatitis B virus infection by
highly viremic pregnant women: a case series. Dig Dis Sci
2012;57(9):2423-9.
69
Mohan P, Colvin C, Glymph C, et al. Clinical spectrum and histopathologic
features of chronic hepatitis C infection in children. J Pediatr
2007;150(2):168-74, 74 e1.